Company / SG&A Expense
LifeMD, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$57.9M
FY2025
5-year range
$39.5M / $57.9M
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 3 consecutive years, from $40M in FY2022 to $58M in FY2025.
Based on SEC 10-K filings.
$58M in FY2025 with a 5-year CAGR of +89.1%.
Increased from $47M to $58M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- +89.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- LifeMD, Inc.'s sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +89.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 12.1% year-over-year.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.9M | +12.1% |
| FY2024 | $51.7M | +10.1% |
| FY2023 | $47.0M | +18.8% |
| FY2022 | $39.5M | -12.1% |
| FY2021 | $45.0M | +1774.3% |
| FY2020 | $2.4M | +4.8% |
| FY2019 | $2.3M | +208.5% |
| FY2018 | $742.0K | -28.1% |
| FY2017 | $1.0M | +211.5% |
| FY2016 | $331.4K | +4.7% |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026